Halozyme Therapeutics (HALO) Tops Q3 EPS by 6c; Raises Outlook

Go back to Halozyme Therapeutics (HALO) Tops Q3 EPS by 6c; Raises Outlook
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.27 +1.59 (1.45%)
Previous Close $109.68    52 Week High $18.39 
Open $109.72    52 Week Low $6.96 
Day High $111.89    P/E N/A 
Day Low $109.38    EPS $-0.58 
Volume 6,176,436